Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4794342
Max Phase: Preclinical
Molecular Formula: C34H42ClN3O7
Molecular Weight: 640.18
Molecule Type: Unknown
Associated Items:
ID: ALA4794342
Max Phase: Preclinical
Molecular Formula: C34H42ClN3O7
Molecular Weight: 640.18
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1ccc(C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)N[C@@H](CC(C)C)C(=O)c2ccco2)cc1
Standard InChI: InChI=1S/C34H42ClN3O7/c1-21(2)18-26(30(39)29-8-7-17-44-29)36-31(40)27(19-22-9-13-24(35)14-10-22)37-32(41)28(38-33(42)45-34(3,4)5)20-23-11-15-25(43-6)16-12-23/h7-17,21,26-28H,18-20H2,1-6H3,(H,36,40)(H,37,41)(H,38,42)/t26-,27-,28-/m0/s1
Standard InChI Key: XZDIKWKGTBGAOI-KCHLEUMXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 640.18 | Molecular Weight (Monoisotopic): 639.2711 | AlogP: 5.52 | #Rotatable Bonds: 14 |
Polar Surface Area: 135.97 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.71 | CX Basic pKa: | CX LogP: 5.67 | CX LogD: 5.67 |
Aromatic Rings: 3 | Heavy Atoms: 45 | QED Weighted: 0.20 | Np Likeness Score: -0.49 |
1. Sun Q,Zhou T,Xi D,Li X,Lü Z,Xu F,Wang C,Niu Y,Xu P. (2020) Design and synthesis of tripeptidyl furylketones as selective inhibitors against the β5 subunit of human 20S proteasome., 192 [PMID:32146375] [10.1016/j.ejmech.2020.112160] |
Source(1):